Silver colloid dressings score over conventional dressings in diabetic foot ulcer: a randomized clinical trial

Rajkumar Sharma; Niraj Gupta; Vipan Kumar; Sanjay Pal; Vishal Kaundal; Vikrant Sharma

doi:10.18203/2349-2902.isj20173401

Authors

Rajkumar Sharma Department of General Surgery, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India
Niraj Gupta Department of General Surgery, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India
Vipan Kumar Department of General Surgery, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India
Sanjay Pal Department of General Surgery, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India
Vishal Kaundal Department of General Surgery, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India
Vikrant Sharma Department of General Surgery, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India

DOI:

https://doi.org/10.18203/2349-2902.isj20173401

Keywords:

Diabetic ulcer, Nano silver in diabetic ulcer, Silver colloid in diabetic ulcer

Abstract

Background: Topical silver treatments and silver dressings are increasingly used for the local treatment of contaminated or infected wounds; however, there is a lack of clarity regarding the evidence for their effectiveness. To compare the outcome of silver colloidal based dressing in comparison to conventional dressing in management of diabetic foot ulcers.

Methods: This was a single institution prospective randomized controlled trial. Patients with Wagner grade 1and 2 diabetic foot ulcer were enrolled in this study. Patients were assessed on day one and then at two weeks interval for twelve weeks for ulcer size by planimetry.

Results: Out of 25 patients, 13 were randomized to silver colloid group and 12 in conventional dressing group. Age and sex distribution was comparable among two groups. Total 29 ulcers were present in silver colloidal and conventional dressing group. Mean wound area in silver colloidal dressing group and conventional dressing group on admission was 36.8 and 20.46 cm² respectively. After 12 weeks of dressing mean wound area in silver colloidal dressing group and conventional dressing group decreased by 31.52 (85.65%) and 14.04 (68.62%) and after 12-week complete healing was seen in 11 (84.62%) patients in silver colloidal dressing group and 5 (41.67) patients in conventional dressing group.

Conclusions: The results suggest that silver colloidal based dressing had significantly better outcome in form of complete healing and decrease in ulcer size in comparison to conventional dressing in diabetic foot ulcers (p value <0.05).

Metrics

Metrics Loading ...

Author Biography

Vipan Kumar, Department of General Surgery, Dr RPGMC Kangra at Tanda, Himachal Pradesh, India

Senior Resident, Dept of Surgery

References

O’Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg. 2001;88(1):4-21.

O’Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev. 2013;12.

Jørgensen B, Price P, Andersen KE, Gottrup F, Bech‐Thomsen N, Scanlon E, et al. The silver‐releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial. Int Wound J. 2005;2(1):64-73.

White R, Cutting KF, Kingsley A. Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage. 2006;52:8, 27-58.

Smoot III EC, Kucan JO, Roth A, Mody N, Debs N. In vitro toxicity testing for antibacterials against human keratinocytes. Plastic Reconstructive Surg. 1991;87(5):917-24.

McCauley RL, Linares HA, Pelligrini V, Herndon DN, Robson MC, Heggers JP. In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res. 1989;46(3):267-74.

Brett DW. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy Wound Manage. 2006;52:1,34-41.

Percival SL, Bowler PG, Russell D. Bacterial resistance to silver in wound care. J Hosp Infect. 2005;60:1,1-7.

Lansdown AB. Silver absorption and antibacterial efficacy of silver dressings. J Wound Care. 2005;14:4,155-160.

Thomas S, McCubbin P. An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care. 2003;12:8,101-7.

Meaume S, Vallet D, Morere MN, Téot L. Evaluation of a silver releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14:10,411-9.

Munter KC, Beele H, Russel L, Gröchenig E, Basse P, Crespi A, et al. Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. J wound care. 2006;15(5):199-206.

Nair LS, Laurencin CT. Silver nanoparticles: Synthesis and therapeutic application. J Biomed Nanotech. 2007;3:301-16.

Dowsett C. The use of silver-based dressings in wound care. Nursing Standard. 2004;19(7):56-60.

Russell AD, Hugo WB. Antimicrobial activity and action of silver. Progress in Medical Chemistry 1994;31:351-71.

Klasen HJ. A historical review of the use of silver in the treatment of burns. Burns. 2000;26:117-38.

White RJ. An historical overview of the use of silver in wound management. Br J Nur. 2001;10:3-8.

Thompson S. Bailey JC (ed). Comprehensive Inorganic Chemistry. Oxford, UK: Pergamon Press; 1973:79-128.

Lansdown AB. Silver I: Its antimicrobial properties and mechanism of action. J Wound Care. 2002;11:125-30.

Modak SM, Fox CL. Sulfadiazine silver-resistant Pseudomonas in burns. New topical agents. Archives of Surg. 1981;116(7):854-7.

Ovington LG. The truth about silver. ostomy/wound management 2004;50(Suppl 9A):1-10.

Mertz PM. Cutaneous biofilms: friend or foe. Wounds. 2003;15(5):129-32.

Innes ME, Umraw N, Fish JS, Gomez M, Gantofto RC. The use of silver coated dressings on donor site wounds: a prospective controlled matched pair study. Burns. 2001;6: 621-7.

Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends in biotechnology. 2010;28(11):580-8.

Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ostomy/wound management. 2001;47(10):38-43.

Sharp KA, McLaws ML. Wound dressings for surgical sites. Cochrane Database of Sys tematic Reviews. 2001(2).

Lewis R, Whiting P, Ter Riet G, O’Meara S, Glanville J. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technology Assessment 2001;5(14):1-131.

Reiber GE. The burden of diabetic foot ulcers. Am J. Surg. 1998;176(2):55-195.

Levin ME. The Diabetic Foot: Pathophysiology, evaluation and treatment. In: Levin ME, O, Neal LW, eds. The Diabetic foot. St Louis Mosby Co. Mosby Year book; 1988:7-27.

Keidig NR, Root HF and Marble A. Importance of control of diabetes in the prevention of vascular complications. JAMA. 1952;150:964.

Pecoraro RE, Reiber GE, Burgess EM. Pathways to Diabetic Limb Amputation: Basis for Prevention. Diabetes Care. 1990;13:513-21.

Lee PY, Ho CM, Lui VCH et al. Silver nanoparticles mediate differential response in keratinocytes and fibroblasts during skin wound healing. Chem Med Chem: chemistry enabling drug discovery. 2010;5(3):468-475.

Burell RE, Nadworny P. Nanocrystalline silver: Noevel structure and activity proceeding of third international conference on the development of BME in Vietnam,11-14th jan 2010.

Van Den Broek PJ, Buys LMF, Van Furth R. Interaction of povidine iodine compounds, phagocytic, cells and microorganisms. Antimicrob Agents Chemothers. 1982;22:593-7.

Rayman G, Rayman A, Baker NR, Jurgeviciene N, Dargis V, Sulcaite R, et al. Sustained silver-releasing dressing in the treatment of diabetic foot ulcers. Br J Nur. 2005;14(2).